Equities

Visioneering Technologies Inc

VTI:ASX

Visioneering Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.13
  • Today's Change-0.01 / -7.14%
  • Shares traded10.58k
  • 1 Year change-45.67%
  • Beta1.9844
Data delayed at least 20 minutes, as of Jul 26 2024 02:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Visioneering Technologies, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture, sale and distribution of a contact lens, the NaturalVue Multifocal 1 Day (NaturalVue MF) contact lens. The Company operates through two segments: North America and Europe / Asia-Pacific. The North America segment includes its operations in the United States and Canada. The Europe/Asia-Pacific segment includes its operations outside of North America. Its flagship product is the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens for adults with Presbyopia and children with Myopia. The Company sells its contact lenses in the United States, Europe, Australia, New Zealand, Hong Kong, Singapore, Canada and Malaysia. The Company manages the warehousing and distribution of its products through a contract with a third-party logistics provider (the 3PL).

  • Revenue in AUD (TTM)13.26m
  • Net income in AUD-5.28m
  • Incorporated2008
  • Employees--
  • Location
    Visioneering Technologies Inc10745 Westside Way, Suite 200ALPHARETTA 30005United StatesUSA
  • Phone+1 (844) 884-5367
  • Fax+1 (302) 636-5454
  • Websitehttps://vtivision.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oakridge International Ltd1.21m-419.38k1.86m----1.46--1.55-0.0244-0.02440.07010.04730.67981.2515.31---23.65-32.81-36.89-51.4371.3066.81-34.78-66.311.80-8.760.2949--121.18-2.8177.98---12.21--
VIP Gloves Ltd5.17m-15.35m2.39m4.00------0.4617-0.0195-0.01950.00660.00050.33078.4412.67---98.16-9.23-160.84-16.91-62.5817.80-296.82-10.080.2919-49.790.798---77.542.47-256.38---13.66--
Tali Digital Ltd455.99k-4.16m3.30m5.00--1.41--7.23-0.0013-0.00130.00010.00070.1031--12.03---94.15-57.47-108.73-66.96-----913.27-552.39----0.00---11.379.7467.44---7.72--
Allegra Medical Technologies Ltd-1.07m-2.69m3.47m4.00k---------0.0245-0.0395-0.0098-0.0135-0.3718-------93.15-21.72-2,036.46-29.07--58.84---49.44---6.88----1,200.00-87.74-3.50---49.57--
Uscom Ltd3.39m-2.10m4.74m11.00--1.68--1.40-0.0119-0.01190.01920.01130.53880.66786.87---33.36-28.64-48.04-33.7184.2085.58-61.91-49.931.31-21.480.5863--3.63-0.8707-31.36---8.50--
Inhalerx Ltd1.21m-1.44m4.74m----7.13--3.93-0.0076-0.00760.00640.00350.629--2.89---75.27-80.34-112.38-99.88-----119.67-500.13---175.270.4571--2,226.0922.7925.10------
Opyl Ltd608.59k-2.38m5.12m3.00------8.42-0.0235-0.02350.0059-0.00050.8679--39.04---339.72-146.86---268.70-----391.44-233.61---6.03-----31.539.4617.22------
Osteopore Ltd2.22m-4.87m5.86m----6.81--2.64-0.0901-0.09010.04150.00750.63862.083.23---140.31---387.70--73.78---219.71--0.6869-448.580.7165--31.02---16.13------
Bluechiip Ltd720.41k-5.85m7.09m7.00--4.25--9.84-0.0068-0.00680.00080.00140.14810.12070.7382---120.26-50.46-305.73-61.9864.1760.32-812.09-605.140.265-58.500.2676---1.3210.26-64.78--9.49--
Visioneering Technologies Inc13.26m-5.28m7.15m----0.7732--0.5395-0.156-0.1560.38840.16811.041.9510.25---41.20-76.38-50.73-97.7054.9044.90-39.80-98.702.85--0.00--19.0121.3641.05------
Global Health Limited8.68m-6.47m8.13m49.00------0.9367-0.1116-0.11160.1495-0.04741.63--20.58---121.53-31.61-970.81-80.8886.6776.70-74.59-36.02---30.84----19.608.60-293.08---13.54--
Control Bionics Ltd6.43m-4.82m10.56m----0.9966--1.64-0.0471-0.04710.06260.05320.64431.983.75---48.27-35.68-54.75-38.8176.5166.18-74.92-96.312.89-293.800.0101--25.1545.937.70--99.91--
Data as of Jul 26 2024. Currency figures normalised to Visioneering Technologies Inc's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.